Xiling Guo

3.6k total citations
39 papers, 1.5k citations indexed

About

Xiling Guo is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Xiling Guo has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Xiling Guo's work include SARS-CoV-2 and COVID-19 Research (11 papers), Viral Infections and Vectors (11 papers) and Fire effects on ecosystems (6 papers). Xiling Guo is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (11 papers), Viral Infections and Vectors (11 papers) and Fire effects on ecosystems (6 papers). Xiling Guo collaborates with scholars based in China, United States and Taiwan. Xiling Guo's co-authors include Lunbiao Cui, Yiyue Ge, Minghao Zhou, Zhiyang Shi, Xian Qi, Yongjun Jiao, Wenshuai Zhang, Ying Chi, Fengcai Zhu and Kangchen Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Xiling Guo

38 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiling Guo China	20	971	341	259	192	168	39	1.5k
Na‐Young Ha South Korea	15	422 0.4×	205 0.6×	71 0.3×	44 0.2×	90 0.5×	31	939
Catherine L. Wilhelmsen United States	20	334 0.3×	335 1.0×	123 0.5×	36 0.2×	272 1.6×	35	1.3k
Aihua Zheng China	20	767 0.8×	217 0.6×	67 0.3×	24 0.1×	213 1.3×	63	1.4k
Hyeok-Il Kwon South Korea	19	597 0.6×	182 0.5×	86 0.3×	48 0.3×	736 4.4×	51	1.2k
Kangchen Zhao China	16	436 0.4×	342 1.0×	19 0.1×	19 0.1×	320 1.9×	27	1.0k
Malin Karlsson Sweden	12	350 0.4×	219 0.6×	64 0.2×	102 0.5×	249 1.5×	20	894
José Luiz Proença‐Módena Brazil	23	570 0.6×	191 0.6×	102 0.4×	10 0.1×	352 2.1×	75	1.3k
Adam J. Hume United States	19	778 0.8×	315 0.9×	75 0.3×	4 0.0×	452 2.7×	38	1.3k
Eric C. Mossel United States	19	853 0.9×	118 0.3×	67 0.3×	15 0.1×	164 1.0×	35	1.1k
Ultan F. Power United Kingdom	32	903 0.9×	492 1.4×	20 0.1×	17 0.1×	1.7k 10.1×	76	2.9k

Countries citing papers authored by Xiling Guo

Since Specialization

Citations

This map shows the geographic impact of Xiling Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiling Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiling Guo more than expected).

Fields of papers citing papers by Xiling Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiling Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiling Guo. The network helps show where Xiling Guo may publish in the future.

Co-authorship network of co-authors of Xiling Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiling Guo. A scholar is included among the top collaborators of Xiling Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiling Guo. Xiling Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lü, Ming, Yin Chen, Xiaoyu Liu, et al.. (2025). Isolation of neutralizing antibodies against SARS-CoV-2 through an epitope-guided negative screening by phage display. Journal of Biomedical Research. 40(2). 210–210.

Xia, Xin, Zhongming Tan, Rong Tang, et al.. (2023). Environmental Impact Assessment for the Use of an Orally Aerosolized Adenovirus Type-5 Vector-Based COVID-19 Vaccine in Randomized Clinical Trials. The Journal of Infectious Diseases. 228(6). 715–722. 1 indexed citations

Jin, Pengfei, Xiling Guo, Jiahong Zhu, et al.. (2023). The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18–59 Years and over 60 Years Based on Two Randomized Controlled Trials in China. Vaccines. 11(12). 1815–1815. 3 indexed citations

Wu, Yanfei, Mingwei Wei, Ruijie Wang, et al.. (2023). Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, immunobridging trial. Expert Review of Vaccines. 22(1). 662–670. 2 indexed citations

Jin, Pengfei, Xiling Guo, Wei Chen, et al.. (2022). Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial. PLoS Medicine. 19(5). e1003953–e1003953. 23 indexed citations

Guo, Xiling, Yin Chen, Ling Wang, et al.. (2021). In vitro inactivation of SARS-CoV-2 by commonly used disinfection products and methods. Scientific Reports. 11(1). 2418–2418. 81 indexed citations

Meng, Fanyue, Fan Gao, Xiànghóng Wú, et al.. (2021). Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials. Signal Transduction and Targeted Therapy. 6(1). 271–271. 23 indexed citations

Dai, Lianpan, Xiaoli Feng, Ran Gao, et al.. (2021). Fast and long-lasting immune response to S-trimer COVID-19 vaccine adjuvanted by PIKA. Molecular Biomedicine. 2(1). 29–29. 10 indexed citations

Hu, Jianli, Zhifeng Li, Xiling Guo, et al.. (2018). A cluster of cases of severe fever with thrombocytopenia syndrome bunyavirus infection in China, 1996: A retrospective serological study. PLoS neglected tropical diseases. 12(6). e0006603–e0006603. 22 indexed citations

10.

Li, Zhifeng, Jianli Hu, Lunbiao Cui, et al.. (2017). Increased Prevalence of Severe Fever with Thrombocytopenia Syndrome in Eastern China Clustered with Multiple Genotypes and Reasserted Virus during 2010–2015. Scientific Reports. 7(1). 6503–6503. 37 indexed citations

11.

Liang, Shuyi, Xiling Guo, Wei Wang, et al.. (2017). Experimental infections of mosquitoes with severe fever with thrombocytopenia syndrome virus. Infectious Diseases of Poverty. 6(1). 78–78. 3 indexed citations

12.

Shi, Fengjuan, Xiaoyan Zeng, Lu Song, et al.. (2016). Establishment of a double-antibody sandwich ELISA for the detection of shiga toxin type II in shiga toxin-producing Escherichia coli infection. Zhonghua weishengwuxue he mianyixue zazhi. 36(10). 771–774. 1 indexed citations

13.

Jiao, Yongjun, Xian Qi, Dapeng Liu, et al.. (2015). Experimental and Natural Infections of Goats with Severe Fever with Thrombocytopenia Syndrome Virus: Evidence for Ticks as Viral Vector. PLoS neglected tropical diseases. 9(10). e0004092–e0004092. 34 indexed citations

14.

Guo, Xiling, Xian Qi, Lunbiao Cui, et al.. (2014). Complete Genome Sequence of a Novel Reassortant Avian Influenza H9N9 Virus Isolated from Chicken in Eastern China. Genome Announcements. 2(5). 1 indexed citations

15.

Liang, Shuyi, Changjun Bao, Minghao Zhou, et al.. (2013). Seroprevalence and Risk Factors for Severe Fever with Thrombocytopenia Syndrome Virus Infection in Jiangsu Province, China, 2011. American Journal of Tropical Medicine and Hygiene. 90(2). 256–259. 47 indexed citations

16.

Qi, Xian, Zheng Zhu, Xiling Guo, et al.. (2013). A novel pyrosequencing assay for the detection of neuraminidase inhibitor resistance-conferring mutations among clinical isolates of avian H7N9 influenza virus. Virus Research. 179. 119–124. 13 indexed citations

17.

Li, Yan, Tao Wu, Xian Qi, et al.. (2013). Simultaneous detection of hemagglutinin and neuraminidase genes of novel influenza A (H7N9) by duplex real-time reverse transcription polymerase chain reaction. Journal of Virological Methods. 194(1-2). 194–196. 11 indexed citations

18.

Qi, Yuhua, Lunbiao Cui, Yiyue Ge, et al.. (2012). Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection. BMC Infectious Diseases. 12(1). 384–384. 114 indexed citations

19.

Cui, Lunbiao, Yuhua Qi, Haijing Li, et al.. (2011). Serum MicroRNA Expression Profile Distinguishes Enterovirus 71 and Coxsackievirus 16 Infections in Patients with Hand-Foot-and-Mouth Disease. PLoS ONE. 6(11). e27071–e27071. 67 indexed citations

20.

Tong, Suxiang, Christina Conrardy, Susan Ruone, et al.. (2009). Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya. Emerging infectious diseases. 15(3). 482–485. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact